Drugs / FOSTAMATIN
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01197781 | Sep → Oct 2010 | — | AstraZeneca | Completed | No outcome recorded |
Press releases naming this drug 1 release
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FOSTAMATIN | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01197781 ↗ |
| Known as | Fostamatinib disodium | “An Open-label, Single-Centre Study to Assess the Pharmacokinetics of R406 in Healthy Volunteers When Fostamatinib Disodium 150 mg is Administered Alone and in Combination With Verapamil” NCT01197781 ↗ |
| Route | Oral | “Oral tablets - single dose” NCT01197781 ↗ |